Results 41 to 50 of about 626 (142)

A Comprehensive Disproportionality Analysis of Drug‐Related Head Injury Reports Using the FAERS Database

open access: yesBrain and Behavior, Volume 16, Issue 6, June 2026.
ABSTRACT Objective This study aimed to identify and characterize drugs associated with reports of head injury through a comprehensive analysis of the FDA Adverse Event Reporting System (FAERS) database. Methods A retrospective disproportionality analysis was conducted on FAERS reports from 2004 to 2023.
Jiaqi Guo   +5 more
wiley   +1 more source

The use of medications approved for alcohol use disorders in Italy

open access: yesFrontiers in Public Health, 2023
BackgroundItaly has the highest per capita alcohol consumption among European countries. Several pharmacological treatments for alcohol use disorders (AUDs) are currently available in Italy, but no consumption data are available.
Filomena Fortinguerra   +2 more
doaj   +1 more source

Sodium Oxybate-Induced Sleep Driving and Sleep-Related Eating Disorder

open access: yes, 2011
Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use.
Wallace, Douglas Mckay   +5 more
core   +1 more source

Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview

open access: yesMedComm, Volume 7, Issue 6, June 2026.
The role of deuterium replacement in drug discovery, its progress, opportunities, and challenges. ABSTRACT Deuterium, the heavy isotope of hydrogen, has unfolded as a cornerstone in modern drug discovery due to its potential to influence metabolic stability and pharmacokinetic behavior.
Mukta Lele   +7 more
wiley   +1 more source

Intraoperative use of sodium oxybate to prevent postoperative delirium in older patients undergoing major orthopedic surgery

open access: yesBMC Medicine
Background This matters arising article addresses the recently published article in BMC Medicine by Cui et al., titled “Prophylactic effect of intraoperative sodium oxybate on postoperative delirium in older patients undergoing major orthopedic surgery ...
Fu-Shan Xue   +2 more
doaj   +1 more source

Sodium Oxybate: A Cause of Extreme Involuntary Weight Loss in a Young Lady

open access: yesCase Reports in Medicine, 2019
We present a case of a young lady with extreme involuntary weight loss and alarming constitutional symptoms found ultimately to be all due to a single medication’s side effects.
Michael G. Noujaim   +2 more
doaj   +1 more source

Towards Mechanism‐Informed Treatments for Mental Health

open access: yesJournal of Neurochemistry, Volume 170, Issue 5, May 2026.
Neuropsychiatric disorders impose a major global health burden, and current treatments, which historically mostly targeted dopamine and serotonin dysfunctions, often provide only partial, symptomatic relief. This review highlights emerging evidence that additional neuromodulator systems, including acetylcholine, norepinephrine, and endocannabinoids ...
Iker Bengoetxea de Tena   +27 more
wiley   +1 more source

Comparative efficacy of sodium oxybate versus placebo on improvement of nighttime sleep in adult patients with narcolepsy: A systematic review and meta-analysis

open access: yesSleep Medicine: X
Background: Narcolepsy, a central hypersomnolence disorder, disrupts sleep regulation. Sodium oxybate, a CNS (central nervous system) depressant, is widely used as a treatment, but there are surprisingly very few rigorous studies comparing its ...
Adina Arshad   +6 more
doaj   +1 more source

Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate

open access: yesFrontiers in Neurology, 2014
Aim: Hypnagogic and hypnopompic hallucinations are characteristic symptoms of narcolepsy, as are excessive daytime sleepiness, cataplexy and sleep paralysis.
Tomi eSarkanen   +7 more
doaj   +1 more source

Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature

open access: yesEpilepsia Open, Volume 11, Issue 2, Page 577-591, April 2026.
Abstract Objective Sialidosis type I (ST‐1) is an autosomal‐recessive, very rare, progressive lysosomal storage disorder caused by pathogenic variants in NEU1. It is clinically characterized by progressive ataxia, myoclonic seizures (MS), bilateral tonic–clonic seizures (BTCS), and distinctive ophthalmological findings.
Janina Gburek‐Augustat   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy